Cora Health Review
Best for: Cash-sensitive patients comfortable with compounded-only sourcing who want flat-rate pricing, named pharmacy disclosure, and LegitScript certification at $99-$135/mo on annual plans
DTC compounded GLP-1 telehealth (Leanio Health LLC dba Cora Health, Delaware) offering compounded semaglutide $99-$175/mo and compounded tirzepatide $135-$225/mo with flat-rate per-tier pricing (no dose-escalation surcharge). Two named 503A compounding pharmacy partners disclosed: Hallandale Pharmacy (Pharmcore Inc, Fort Lauderdale FL, PCAB-accredited, since 2003) and VialsRx. LegitScript Certified (seal ID 49690100). Clinical via Wasef Health PC (Michael Wasef MD). All 50 states, HSA/FSA accepted, no membership fee.
Medium confidence · Last verified 2026-05-27 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Cora Health is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
Cora Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Monthly plan (all doses) | compounded | $175 |
| 3-month plan (all doses) | compounded | $145 |
| 6-month plan (all doses) | compounded | $120 |
| 12-month plan (all doses) | compounded | $99 |
| Monthly plan (all doses) | compounded | $225 |
| 3-month plan (all doses) | compounded | $199 |
| 6-month plan (all doses) | compounded | $175 |
| 12-month plan (all doses) | compounded | $135 |
✓ Pros
- •Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
- •Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
- •LegitScript Certified (seal ID 49690100 in footer)
- •Flat per-tier pricing — no dose-escalation surcharge
- •Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide
- •All 50 states with HSA/FSA accepted
- •Wasef Health PC clinical group with named physicians (Wasef MD, Chen DO, Okafor MD)
- •No FDA Warning Letters
- •Free expedited shipping included
✗ Cons
- •Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
- •Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
- •Lowest advertised prices require 12-month commitment with no partial refunds
- •No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
- •Founder names and funding undisclosed on site
- •Wasef Health PC clinical group is third-party (not Cora-employed physicians)
Ready to start with Cora Health?
Starting at $99/month. See current pricing and start your free consultation.
Sources & methodology
Our Cora Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Cora Health
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Cora Health?
Starting at $99/month. See current pricing and start your free consultation.